Form 4: Savara Director Nevan Elam Receives RSU Grant

Savara Inc. Director Nevan Elam was granted 40,000 restricted stock units, vesting in December 2026, increasing his beneficial ownership to 106,887 shares.

Summary

• Nevan C. Elam, a Director of Savara Inc. (SVRA), acquired 40,000 shares of common stock.
• The acquisition was in the form of Restricted Stock Units (RSUs) with a transaction price of $0.00 per share.
• These RSUs are scheduled to vest in full on December 9, 2026, contingent upon Mr. Elam's continued service with Savara Inc.
• Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• Mr. Elam has elected to defer the receipt of these shares until his termination of service with the Issuer.
• Following this transaction, Mr. Elam beneficially owns a total of 106,887 shares of Savara Inc. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is a positive sign of continued alignment between management and shareholder interests, reinforcing commitment. It's a routine compensation event, not indicative of extraordinary news, hence a moderate positive score.

Positives

• Director Nevan Elam received a grant of 40,000 Restricted Stock Units (RSUs), aligning his interests with long-term shareholder value.
• The increase in beneficial ownership to 106,887 shares demonstrates continued commitment from a key director.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned and transparent equity award.

Risks

• The vesting of the 40,000 RSUs is subject to Nevan Elam's continued service with Savara Inc. until December 9, 2026.

Future Outlook

The RSUs vest on December 9, 2026, contingent on continued service, indicating a future commitment period for the director. The deferral election means shares will be delivered upon termination of service.

Industry Context

This is a standard equity compensation event for a director, common across publicly traded companies, particularly in sectors like biotech/pharma, to align director incentives with long-term company performance.

Comparison to Industry Standards

• Granting Restricted Stock Units (RSUs) to directors as part of compensation is a common practice in publicly traded companies, aligning director interests with shareholder value.
• The vesting schedule, typically over one to three years, is standard for such equity awards, promoting retention and long-term commitment.
• The deferral election by the director is also a common feature in executive compensation plans, allowing for tax planning and continued alignment post-service.

Corporate Governance

Related Party Transactions

• Grant of 40,000 Restricted Stock Units (RSUs) to Nevan C. Elam, a Director of Savara Inc., as part of his compensation.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with long-term shareholder value, potentially fostering better governance and strategic decisions.
• Management: Reinforces the commitment of a key director to the company's future.

Next Steps

• The 40,000 Restricted Stock Units are scheduled to vest on December 9, 2026.
• Shares underlying the vested RSUs will be delivered to Nevan Elam following his termination of service with Savara Inc., as per his deferral election.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director, which is a standard compensation practice and does not provide new fundamental information to warrant a change in investment recommendation. It indicates continued alignment of director interests with the company's long-term performance but does not signal a significant shift in the company's prospects or valuation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

Savara Inc, SVRA, Nevan Elam, Restricted Stock Units, RSU, Director Compensation, Insider Ownership, Form 4, Equity Grant, Stock Award